ARCHIVES

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 32 No. 29 | July 28, 2006

Download PDF Visit The Full Archive

Related Articles

In Congress: Human Genome Project Ahead Of Schedule, Collins Assert

March 27, 1998

ACS Funds $54 Million in Grants

June 28, 2002

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

March 25, 2011

Conversation with The Cancer Letter: Daniel Hayes Leads Tour of Caris Website

August 8, 2014

Study Suggests Biomarker For Resistance to Tamoxifen

March 25, 2011

TGen and George Mason Form Precision Medicine Alliance

May 16, 2014